Although macrophages, neutrophils, mast cells, and tumor cells treated with a GPR55 antagonist decrease their migratory behavior (17, 19, 46, 54), we observed increased migration of pan-T cells, isolated from healthy GPR55 KO mice. Here, GPR55 is linked to neoplasm.